FOLH1 and prostate carcinoma: Different studies revealed that the sequence Glu-C(O)-AA, with AA as a variable amino acid, is a potent inhibitor of glutamate carboxypeptidase II (GCPII) (see, e.g., [147]), an enzyme highly expressed on prostate carcinoma cells and also known as PSMA.